showed that in breast cancer cell lines treated with paclitaxel, DNMT3a positively regulated LINE-1 mRNA expression levels by increasing methylation within the LINE-1 gene, while promoting the development of a drug-resistant phenotype in breast cancer (83). This evidence concerns the gene DNMT3A and breast cancer.